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Cell cycle arrestExposure to ultraviolet B (UVB) irradiation (290–320 nm wavelength) from sunlight induces a variety of
medical problems, including sunburn, immunosuppression and skin cancers. However, the molecular
mechanisms related to UVB-induced cell damage and/or mutagenic effects have not been fully deﬁned. Here,
we demonstrate that one of the catalytic subunits of the IκB kinase complex (IKK), IKKα, plays a critical role
in mediation of the UVB-induced G0/G1 cell cycle arrest response by suppressing Cyclin D1 expression.
Notably, IKKa-dependent Cyclin D1 regulation is unrelated to IKKβ/NF-κB activity. We further show that
IKKα-dependent downregulation of Cyclin D1 expression in the UVB response results from the reduction of
ERK1/2-dependent Cyclin D1 transcription coupled with an increase of p38 kinase-dependent Cyclin D1
proteolysis. Thus, our results have identiﬁed the novel role of IKKα in regulating cell cycle progression during
the cellular UVB response. Targeting IKKα might be promising for the prevention of UVB-induced cell
damage and tumorigenic effects.d at tel.: +86 10 66932327;
519; fax: +1 845 351 2320.
anshu@env.med.nyu.edu
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
The ultraviolet (UV) spectrum from sunlight can be separated into
three wavelengths, UVA (320–400 nm), UVB (290–320 nm) and UVC
(200–290 nm). UVB has been identiﬁed as the most harmful
environmental stressor, which is implicated in a variety of medical
problems, including sunburn and skin cancers [1]. Cell cycle arrest and
apoptosis are two major protective responses against UVB-induced
cell damage and mutagenic effects, which allow time for repair of the
DNA damage or move the severely damaged cells towards apoptosis.
Deregulation of either (or both) response contributes largely to the
UVB-related pathogenesis [1,2].
Cyclin D1 plays a crucial role in determining G1 to S cell cycle
progression. It can form an active complex with cyclin-dependent
kinases 4 and 6 (CDK4 and CDK6) and promote the initiation of
the G1/S cell cycle transition by phosphorylating and inactivating
the retinoblastoma protein (pRB), a gatekeeper of the G1 phase.
Consequently, Cyclin D1 expression levels are tightly controlled, and
the deregulated overexpression of this protein has been found to
frequently occur in multiple human cancers [3–5].
As a key cell cycle checkpoint protein, the expression of Cyclin
D1 is regulated at both the transcriptional and post-translational
levels [3–5]. It has been demonstrated that multiple transcriptionalfactors, such as NF-κB, AP-1, TRE, Oct-1, E2F, CRE, SP-1, ELK-1, c-Ets-1
and c-Ets-2, are able to bind directly to the promoter region of
the cyclin d1 gene (CCND1), thereby inducing transcription and
mediating cell proliferation in response to a variety of growth stimuli
[6–9]. Furthermore, the three mitogen-activated protein kinases
(MAPKs), ERKs, JNKs and p38K, are also involved in modulating
cyclin d1 transcription by regulating the activities of distinct tran-
scriptional factors [7,10,11]. In addition to transcriptional induction,
the Cyclin D1 protein is subjected to rapid degradation via the
ubiquitin-dependent pathway after performing its action at the G1/S
transition [3–5]. The signal for targeting Cyclin D1 to the degradation
pathway is largely dependent on phosphorylation at Thr286. GSK-3β,
p38K and ERK2 have been deﬁned as the major protein kinases for
mediating Cyclin D1 Thr286 phosphorylation and thereby inducing its
degradation under different conditions [12–16].
IKKα and IKKβ are catalytic subunits of the IKK complex, which are
responsible for the activation of the NF-κB transcription factor and
have important implications in cell fate determination under various
stress conditions [17]. Although sharing structure similarity, the
mechanisms underlying the actions of IKKα and IKKβ in NF-κB
activation are quite different. IKKβ is involved in canonical NF-κB
pathway activation by triggering the phosphorylation and degrada-
tion of the NF-κB inhibitor, I-κB; while IKKα plays a key role in the
non-canonical NF-κB pathway activation, which depends on the
processing of the NF-κB2/p100 precursor to the p52 subunit [17].
Interestingly, IKKα can also contribute to the canonical NF-κB
pathway activation by binding to the promoter regions of NF-κB-
responsive genes and mediating the phosphorylation of promoter-
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have revealed that IKKα possesses some unique functions essential for
regulating the development of certain tissues and cancer cells, which
cannot be compensated for by IKKβ [8,20–27]. These results indicate
that IKKα may be a multi-functional protein, and its roles may go far
beyond its well-known action in NF-κB pathway regulation.
In the current study, we deﬁne a novel role for IKKα in initiating
the inducible G0/G1 growth arrest response by triggering a rapid
downregulation of Cyclin D1 expression in mouse embryonic
ﬁbroblasts (MEFs) under UVB exposure, which events are indepen-
dent of IKKβ/NF-κB activity. We further provide evidence that the
effect of IKKα in mediating Cyclin D1 downregulation results from the
reduction of ERK-dependent cyclin d1 gene transcription coupled
with an increase of p38 kinase-dependent Cyclin D1 degradation in
response to UVB irradiation. Accordingly, we have established the
independent function of IKKα in mediating the cell cycle checkpoint
under UVB exposure, and this may provide a novel target for the
prevention of UVB-induced cell damage effect.
2. Materials and methods
2.1. Cells, plasmids, viruses and reagents
The wild type (WT), IKKβ−/−, IKKα−/− and stably reconstituted
IKKα−/− (IKKα) MEFs; the p65+/+ and p65−/− MEFs; and the WT
MEFs stably expressing the kinase mutant of IKKβ (IKK-KM) are
described in previous studies [28,29]. The Cyclin D1-luciferase
reporter plasmid, in which the transcription of the luciferase reporter
gene is driven by the upstream 5′-ﬂanking region of the cyclin d1 gene
promoter, has been described previously [30]. The expression plasmid
containing the IκBα-AA mutation was provided by Dr. Yong Lin
(Lovelace Respiratory Research Institute, USA) and was described
previously [31]. WT IKKα and the IKKα kinase mutant (IKKα-KM)
adenoviruses were kindly provided by Dr. Yinling Hu (NIH, BA) and
were described previously [32]. The antibodies against phospho-JNKs,
JNKs, phospho-p38K, p38K, phospho-ERKs, ERKs, phospho-AKT, AKT,
phospho-GSK3α/β, GSK3β, phospho-IKKα/β, IKKα, IKKβ, phospho-
Cyclin D1 and IκBα were purchased from Cell Signaling Technology
(Beverly, MA). The antibodies against Cyclin D1, Cyclin D2, CDK4,
p65 and HA were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA). The kinase inhibitors PD98059, SP600125, SB202190, LiCl,
and the anti-β-actin and anti-FLAG antibodies were obtained from
Sigma (St. Louis, MO). Cycloheximide (CHX), MG132 and DAPI were
purchased from Calbiochem (San Diego, CA).
2.2. UVB apparatus and cell exposure
The UVB light source (CL-1000 M Midrange Ultraviolet Cross-
linker) was purchased from UVP Inc. (Upland, CA) and emitted
302 nmwavelength UVB light. The Crosslinker is designed to measure
and control the UVB radiation within the exposure chamber. A unique
UV sensor continually measures the UVB energy and automatically
adjusts to variations in UVB intensity that occurs as the UVB tubes age.
This same UV sensor feedback measurement system allows us to set
UV samples exposures, which automatically deactivates the UV
sources when the set UV energy dose has been achieved. Before
UVB irradiation, cells seeded in 6-well plates were washed with 2 ml
PBS and replaced with 1 ml fresh PBS each well. Cells were irradiated
at the desired intensity without the plastic lid. After irradiation, cells
were returned to incubation in a regular medium for the various time
periods prior to harvest.
2.3. Cell transfection
All transfections were performed with LipofacTAMINE 2000
reagents (Life Technologies, Inc., Rockville, MD) according to themanufacturer's instructions. To establish the stable Cyclin D1 lucif-
erase reporter construct-transfected WT and IKKα−/− MEFs, the
luciferase reporter plasmid was introduced into the cells together
with lacZ-hygro+, a vector conferring hygromycin-resistance. The
corresponding hygromycin-resistant stable transfectants were estab-
lished as a polyclonal mass under hygromycin B selection. These
transfectants were then cultured in hygromycin-free medium for at
least two passages before subjecting to the various experiments.
2.4. Adenovirus infection
IKKα−/− MEFs were infected with 1×108 p.f.u. adenovirus (GFP,
WT-IKKα or IKKα-KM) at 70–80% conﬂuence. Virus-containing
medium was replaced with fresh medium 24h after infection.
2.5. Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was extracted with Trizol reagent (Gibco) and cDNAs
were synthesized with the ThermoScript™ RT-PCR system (Invitrogen,
Carlsbad, CA). To detect cyclin d1 induction, a pair of oligonucleotides
(5′-TCC CTT GAC TGC CGA GAA G-3′ and 5′-AGA CCA GCC TCT TCC TCC
AC-3′) was synthesized and used as the speciﬁc primers to amplify
mouse cyclin d1 cDNA. Mouse β-actin cDNA was ampliﬁed by the
primers 5′-GACGATGATATTGCCGCACT-3′ and 5′-GATACC ACGCT
TGCTCTGAG-3′.
2.6. Cell cycle assay
Cells seeded in 6-well plates (2×105/well) were starved by
replacing the medium with 0.1% FBS DMEM 24h prior to UVB radia-
tion. UVB exposure was preformed and the cells were then stained
with propidium iodide (PI) solution according to the previous report
[33]. Cell cycle distribution was determined by ﬂow cytometry,
utilizing a Beckman-Coulter EpicsXL ﬂow cytometer. Twenty thou-
sand events were counted for each analysis, and two to four
independent experiments were conducted in each group.
2.7. Western-blot assay
Cellular protein extracts were prepared with cell lysis buffer
(10 mMTris–HCl, pH 7.4, 1% SDS, 1 mMNa3VO4) and resolved by SDS-
PAGE. The membranes were probed with the indicated primary
antibodies and HRP-conjugated secondary antibody. Signals were
detected with the ECL western-blotting system as described in our
previous reports [28,29,33].
2.8. Luciferase reporter assay
MEFs stably expressing the luciferase reporter constructs were
seeded into 96-well plates (8×103/well) and subjected to UV expo-
sure when the cultures reached 80–90% conﬂuence. Cellular lysates
were prepared at the indicated timepoints, and the luciferase activities
were determined by a luminometer (Wallac 1420 Victor 2 multilabel
counter system) as described in our previous studies [30,33]. The
results are expressed as a relative activity that is normalized to the
control cells without treatment.
2.9. Immunoﬂuorescence microscopy
Cells were ﬁxed in cold methanol for 15min and blocked in PBS
containing 2% BSA and 0.2% Triton X-100 for 1h. The samples were
then incubated with anti-Cyclin D1 as the primary antibody, followed
by AlexaFluor488 goat anti-mouse IgG (Invitrogen) as the secondary
antibody. DAPI was used to stain the nucleus. Images were acquired
on an Olympus microscope (Olympus IX71-F22FL/PH).
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3.1. IKKα is required for the UVB-induced G0/G1 growth arrest response
and Cyclin D1 downregulation in MEFs
Growth arrest is a cellular protective response against UVB-
induced damage [1]. To investigate the roles of IKKα and IKKβ in
cellular UVB responses, we ﬁrst analyzed the cell cycle distribution of
WT, IKKα- and IKKβ-gene knockout MEFs (Fig. 1A) in the absence or
presence of UVB exposure. As shown in Fig. 1B, UVB irradiation
induced a signiﬁcant growth arrest at the G0/G1 boundary almost
identically in the WT and the IKKβ−/−MEFs. However, this response
was completely blocked in the IKKα−/− MEFs under the same
conditions. To further conﬁrm these data, we reconstituted IKKα−/−
MEFs with IKKα (Fig. 1C) and then examined whether the UVB-
induced G0/G1 growth arrest response could be rescued in these
reconstituted cells. As predicted, the reconstituted IKKα−/−(IKKα)
cells displayed the same inducible growth arrest response at G0/G1
phase upon UVB exposure (Fig. 1B). Based on these data, we conclude
that the expression of IKKα is required for triggering the UVB-induced
G0/G1 growth arrest response in MEFs.
Cyclin D1 is a key factor for promoting the G1/S transition of the
cell cycle [3–5]. Recently, we reported that the induction of Cyclin D1
downregulation is responsible for the nickel compound-induced
growth arrest response and occurs via the IKKα-dependent pathway
in human lung carcinoma cells [34]. We therefore investigated
whether the IKKα-mediated G0/G1 growth arrest response after
UVB exposure is also related to alterations of endogenous Cyclin D1
expression. As shown in Fig. 1D, a dose-dependent downregulation of
Cyclin D1 protein expression was clearly detected in the WT cells at
12h after UVB exposure. Moreover, this kind of response was not
altered by IKKβ deﬁciency (although the basal level of Cyclin D1 was
extremely low in the IKKβ-null cells), but was signiﬁcantly
suppressed in IKKα-null cells under the same treatment. When
IKKα level was recovered in the reconstituted IKKα−/− MEFs, UVB-
induced Cyclin D1 downregulation could be efﬁciently restored, as
evidenced by both dose- and time-dependent experiments (Fig. 1E
and F). These results thus indicate that, as in the action of nickel in the
human cells [34], UVB-induced G0/G1 growth arrest response in
MEFs is also related to IKKα-dependent reduction of Cyclin D1
expression.
We next examined if deletion of IKKα affected the expression of
other D-type Cyclins, as well as one of their functional partners, CDK4,
in the UVB response. As shown in Fig. 1D, both Cyclin D2 and CDK4
were downregulated with almost the same manners in WT and
IKKα−/− cells, suggesting that genetic ablation of IKKα speciﬁcally
abolished UVB-induced Cyclin D1 downregulation in MEFs.
3.2. The effect of IKKα in mediating UVB-induced Cyclin D1
downregulation is unrelated to IKKα kinase activity and the activation
status of IKKβ/NF-κB
To clarify whether IKKα-dependent Cyclin D1 downregulation
during the UVB response is related to IKKα kinase activity, we next
compared Cyclin D1 levels in the IKKα−/− MEFs reconstituted with
WT IKKα or the IKKα kinase mutant IKKα-KM [32], respectively. As
shown in Fig. 1G, both WT IKKα and IKKα-KM overexpression could
restore the UVB-induced Cyclin D1 downregulation in the IKKα−/−
cells. This result indicates that IKKα kinase activity is not required for
Cyclin D1 downregulation in the UVB response.
As NF-κB activation is involved in Cyclin D1 expression, and
regulation of NF-κB activity is the most important function of IKKα
[17], we next sought to determine if the NF-κB signaling pathway is
related to the process of UVB-induced Cyclin D1 downregulation in
MEFs. To this end, we ﬁrst introduced the IKKβ kinasemutant IKK-KM
into WT MEFs to suppress UVB-induced phosphorylation of IKKβ(Fig. 1H), an upstream event that contributes greatly to NF-κB
pathway activation under various conditions [17]. We found that
ectopic overexpression of IKK-KM in WT cells signiﬁcantly inhibited
NF-κB transactivation (data not shown) but did not affect the
response of Cyclin D1 downregulation induced by UVB irradiation
(Fig. 1H). IκBα-AA is an IκBα super-repressor that efﬁciently blocks
IκBα degradation and NF-κB activation in response to a variety of
stimuli [17,31]. To further conﬁrm the role of NF-κB in Cyclin D1
reduction in the UVB response, we then assayed for Cyclin D1
expression in IκBα-AA-transfected WT cells. We found that down-
regulation of Cyclin D1 expression under UVB exposure was not
altered by ectopic overexpression of IκBα-AA (Fig. 1I), althoughNF-κB
activationwas dramatically inhibited under the same conditions (data
not shown). We further examined Cyclin D1 levels in NF-κB p65
subunit gene knockout MEFs after UVB exposure. The results showed
that the UVB-induced Cyclin D1 downregulation was not affected by
the absence or presence of p65 (Fig. 1J). Taken together, we propose
that the effect of IKKα on suppressing Cyclin D1 expression during the
cellular UVB response is unrelated to the IKKα kinase activity and the
IKKβ/NF-κB-dependent pathway.
3.3. IKKα increases Cyclin D1 degradation via the proteasome during the
UVB response
The cellular levels of Cyclin D1 depend largely on the stability of
this protein. Phosphorylation of Cyclin D1 at Thr286 serves as a crucial
signal for directing Cyclin D1 to the 26S proteasome-dependent
degradation pathway [12–16,35]. To elucidate the molecular mech-
anism by which IKKα downregulates Cyclin D1 expression during the
UVB response, we ﬁrst examined the phosphorylation status and
stability of Cyclin D1 in MEFs after UVB exposure. As shown in Fig. 2A,
along with the remarkable downregulation of Cyclin D1 levels, an
inducible increase of Cyclin D1 phosphorylation at Thr286 was
detected in the UVB-treated WT cells. Moreover, pretreatment with
the proteasome inhibitor MG132 was able to signiﬁcantly suppress
UVB-induced Cyclin D1 downregulation in WT MEFs (Fig. 2B). These
results suggest that the induction of Thr286 phosphorylation and
subsequent degradation of Cyclin D1 via the proteasome-dependent
pathway may constitute at least one molecular mechanism for UVB-
induced Cyclin D1 downregulation in MEFs. However, UVB-induced
Cyclin D1 phosphorylation at Thr286 was blocked in the IKKα-null
cells, which is consistent with the lack of Cyclin D1 downregulation
under the same UVB exposure conditions (Fig. 2A). These data
indicate that IKKα functions as a critical mediator to trigger the
phosphorylation and degradation of Cyclin D1 in the UVB response.
To further conﬁrm the role of IKKα in modulating Cyclin D1
protein stability, we next determined whether IKKα regulated the
turnover of endogenous Cyclin D1 under UVB stress conditions. For
this purpose, WT and IKKα−/− cells were left untreated or exposed to
a signal dose of UVB followed by re-stimulation with cycloheximide
(CHX), a protein synthesis inhibitor to block the de novo production of
proteins. We found that the half-life of Cyclin D1 in the resting WT
MEFs was ~59min and was decreased to ~35min after UVB exposure
(Fig. 2C), indicating an increased degradation of Cyclin D1 protein in
the UVB-treated WT cells. However, the half-life of Cyclin D1 in the
resting IKKα−/− cells was signiﬁcantly extended compared to theWT
cells and did not show obvious changes after UVB exposure (~93min
before UVB exposure vs. ~90min after UVB exposure) (Fig. 2C).
Furthermore, re-introduction of IKKα into the null cells effectively
restored the increased turnover of Cyclin D1 induced by UVB (Fig. 2D).
Taken together, these results indicate that UVB-induced Cyclin D1
downregulation is accomplished, at least partially, by accelerating the
degradation of this protein, which is effectively triggered by IKKα.
It is known that subcellular localization plays a critical role in
regulating the protein stability of Cyclin D1 [3,4,35]. Therefore, we
next analyzed whether IKKα exerted any effect on the subcellular
Fig. 1. IKKα is required for the UVB-induced G0/G1 growth arrest response and Cyclin D1 downregulation in MEFs. (A and C) Identiﬁcation of WT, IKKβ−/−, IKKα−/− and the
reconstituted IKKα−/−(IKKα) MEFs. (B) WT, IKKβ−/−, IKKα−/− and IKKα−/− (IKKα) cells were exposed to UVB (1.0 kJ/m2) and cell cycle distribution were determined by ﬂow
cytometric assay 12h after exposure. (D) WT, IKKβ−/− and IKKα−/− cells were exposed to different doses of UVB and the expression levels of Cyclin D1, Cyclin D2 and CDK4 were
determined by western-blot assay 12h after exposure. (E) WT, IKKα−/− and IKKα−/− (IKKα) cells were exposed to different doses of UVB and the expression levels of Cyclin D1
were detected 12h after exposure. (F)WT, IKKα−/− and IKKα−/− (IKKα) cells were exposed to a single dose (1.0 kJ/m2) of UVB and the expression levels of Cyclin D1were detected
at the indicated time points after exposure. (G) IKKα−/− cells were infected with adenoviruses encoding GFP, wt IKKα or IKKα-KM. The infected cells were exposed to UVB
irradiation 48h after infection and then Cyclin D1 levels were determined 6h after exposure. (H) WT cells were transfected with an expression plasmid containing the IKKβ kinase
mutant IKK-KM or control vector. 48h after transfection, the cells were exposed to UVB and Cyclin D1 levels were detected 12h after irradiation. (I) WT cells were transfected with
the expression plasmid containing HA-IκB-AA or control vector. 36h after transfection, the cells were exposed to different doses of UVB and Cyclin D1 levels were detected 12h after
irradiation. (J) p65+/+ and p65−/− MEFs were exposed to different doses of UVB and then Cyclin D1 levels were detected 12h after exposure.
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immunoﬂuorescence (IF) assays showed that endogenous Cyclin D1
displayed the same predominant nuclear distribution in both resting
WT and IKKα−/− cells (Fig. 2E). However, UVB stimulation triggered a
remarkable nuclear exclusion of Cyclin D1 along with a signiﬁcant
reduction of the Cyclin D1 signal in WT MEFs, but the level andsubcellular distribution of Cyclin D1 remained almost unchanged in
the IKKα−/− cells after the same UVB treatment (Fig. 2E). The
subcellular distribution of Cyclin D1 in IKKβ-null cellswas also assayed
by IF. Consistent with the low basal level of Cyclin D1 protein detected
by western-blotting assay (Fig. 1D), the IF signal for endogenous
Cyclin D1 in IKKβ-null cells was also extremely low and could only
Fig. 2. IKKα increases Cyclin D1 degradation during the UVB response. (A) WT, IKKβ−/− and IKKα−/− cells were exposed to different doses of UVB and the phosphorylation and
expression of Cyclin D1 were determined by western-blot assay 6h after exposure. (B) WT cells were pretreated with 10μMMG132 (10μM) or its vehicle (DMSO) for 1h and then
exposed to different doses of UVB. The Cyclin D1 levels were detected 6h after UVB exposure. The efﬁciency ofMG132 in disrupting the function of the proteasome in this experiment
was veriﬁed by the induced expression of p53, the well-known protein that is constitutively degraded via the proteasome-dependent pathway. (C) WT and IKKα−/−cells were left
untreated or exposed to a single dose of UVB (1.0 kJ/m2) followed by treatment with 10μM CHX. The Cyclin D1 levels were detected at the indicated time points after CHX
stimulation. (D) IKKα−/− and IKKα−/− (IKKα) cells were exposed to a single dose (1.0 kJ/m2) of UVB followed by treatment with 10μM CHX. The Cyclin D1 levels were detected at
the indicated time points after CHX stimulation. (E)WT, IKKβ−/− and IKKα−/− cells were exposed to UVB (1.0 kJ/m2) and then subcellular distribution of Cyclin D1was detected by
immunoﬂuorescence assays at the indicated time points.
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CyclinD1 in the IKKβ-null cells showedawhole-cell distribution under
normal conditions andexhibitednuclear exclusive staining identical to
WT cells underUVB exposure (Fig. 2E). These results suggest that UVB-
induced Cyclin D1 downregulation is predominantly mediated by
IKKα, which induces the signaling pathway to upregulate phosphor-
ylation, trigger nuclear exclusion, and increase the degradation of
Cyclin D1.
3.4. Identiﬁcation of p38 kinase as the downstream effector of IKKα that
mediates increased Cyclin D1 degradation in the cellular UVB response
GSK3β, p38K and ERK2 arewell-deﬁned protein kinases implicated
in mediating Thr286 phosphorylation and degradation of Cyclin D1
under different conditions [12–16]. To determine the signal transduc-
tion pathway initiated by IKKα to accelerate Cyclin D1 degradation
during the UVB response, we compared the activation status of the
aforementioned protein kinases inWT and IKKα−/− cells 1h after UVBexposure, at which time the induced Cyclin D1 degradation was only
observed in WT cells while signiﬁcantly inhibited in IKKα-null cells
(Fig. 2C). As shown in Fig. 3A, a strong induction of p38K phosphory-
lation was readily detected in WT MEFs in response to UVB exposure;
while the amount of phospho-GSK3β and phospho-ERKs was not
obviously changed under the same conditions. Moreover, UVB-
induced p38K activation was signiﬁcantly suppressed by IKKα
deﬁciency, while a slight increase of ERK activation was observed in
the IKKα-null cells under the same conditions. Although GSK3β
phosphorylation was dramatically increased by IKKα ablation, such a
downregulation of GSK3β activity was not altered after UVB exposure
(Fig. 3A). These data thus implicate a major role for p38K, while
excluding the involvement of both ERKs and GSK3β, in mediating
IKKα-dependent Cyclin D1 proteolysis in the UVB response. To further
conﬁrm these results, we next examined the activation status of p38K
in the reconstituted IKKα−/−(IKKα) cells. We found that recovering
the expression of IKKα in the null cells efﬁciently restored the strong
induction of p38K activation in response to UVB irradiation (Fig. 3B).
Fig. 3. p38 kinase functions as the downstream effector of IKKα to mediate increased Cyclin D1 degradation in the UVB response. (A) WT, IKKβ−/− and IKKα−/− cells were exposed
to different doses of UVB and the activation status of p38K, ERKs and GSK3βwas determined by western-blot assay 1h after UVB exposure. (B) WT, IKKα−/− and IKKα−/− (IKKα)
cells were exposed to different doses of UVB and the activation status of p38K was determined by western-blot assay 1h after UVB exposure. (C) WT cells were pretreated with the
inhibitors of JNKs (10μM SP600125), ERKs (50μM PD98059), p38K (20μM SB202190) or their vehicle control (DMSO) for 1h and then left untreated or exposed to UVB irradiation
(1.0 kJ/m2). After treatment with 10μM CHX at the indicated time points, cells were harvested and Cyclin D1 levels were detected by western-blot assay. (D) WT cells were
pretreated with 20μM SB202190 or DMSO for 1h and then exposed to UVB irradiation (1.0 kJ/m2). The phosphorylation and expression of Cyclin D1 were detected at the indicated
time points after UVB exposure.
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IKKα that is responsible for triggering the degradation of Cyclin D1
after UVB exposure.
To determine if the putative IKKα-p38K pathway was indeed
responsible for UVB-induced phosphorylation and degradation of
Cyclin D1 in MEFs, we compared the kinetics of Cyclin D1 turnover
in resting and UVB-treated WT cells in the presence of the p38K
inhibitor, SB202190. As shown in Fig. 3C, compared to the control
(DMSO-treated) group, pretreatment of resting WT cells with
SB202190 did not affect the constitutive degradation of Cyclin D1.
However, the increased Cyclin D1 degradation under UVB stimulation
was signiﬁcantly disrupted, as evidenced by the same kinetics of
Cyclin D1 turnover with or without UVB exposure in the SB202190-
pretreated cells. However, incubation with other protein kinase
inhibitors (SP600125 for JNKs and PD98059 for ERKs) had no effectto elongate the half-life of Cyclin D1 in UVB-treated WT MEFs.
Furthermore, suppression of p38K activation by SB202190 robustly
disrupted UVB-induced Thr286 phosphorylation as well as Cyclin D1
reduction in WT MEFs (Fig. 3D), reminiscent of the similar phenom-
enon observed in IKKα-null cells under the same UVB stress con-
ditions. Therefore, in combination with all of these data, we propose
that p38K is a major downstream effector of IKKα responsible for the
phosphorylation of Cyclin D1 at Thr286 and thereby increasing the
degradation of this protein during the UVB response.
3.5. IKKα suppresses cyclin d1 transcription in response to UVB exposure
In the following experiments, we further explored if IKKα also
plays a role in modulating cyclin d1 transcription during the cellular
UVB response. To this end, a Cyclin D1-luciferase reporter plasmid, in
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cyclin d1 promoter [30], was transfected into WT and IKKα-null cells,
respectively. The established stable transfectants were then exposed
to different doses of UVB, and the luciferase activity was measured
12h after stimulation. As shown in Fig. 4A, a moderate dose-
dependent increase of the Cyclin D1 luciferase reporter activity was
observed in WT MEFs in response to UVB exposure. RT-PCR assay
further conﬁrmed an increase of the endogenous cyclin d1 mRNA
transcripts in WT cells under the same UVB irradiation conditions
(Fig. 4B). These results indicate that the induction of cyclin d1 tran-
scription also constitutes a response in UVB-treated MEFs. Interest-
ingly, the inducible upregulation of cyclin d1 transcription was much
more pronounced in IKKα-null cells compared to WT cells, according
to the same luciferase reporter and RT-PCR assays (Fig. 4A and B).
Moreover, reconstitution of IKKα expression in the IKKα-null cells
signiﬁcantly attenuated the induction of Cyclin D1 promoter-driven
luciferase activity in response to UVB exposure (Fig. 4C). Thus, these
results suggest that in addition to its regulatory role in Cyclin D1
protein stability, IKKα may also possess the ability to suppress UVB-
induced cyclin d1 transcription in MEFs.
3.6. IKKα suppresses UVB-induced cyclin d1 transcription by targeting
the ERK-dependent pathway
To explore the molecular mechanism by which IKKα suppresses
UVB-induced cyclin d1 transcription, we investigated the activation
status of the protein kinases possibly involved in cyclin d1 tran-
scription (JNKs, ERKs and Akt) 12h after UVB exposure, at which time
the induction of cyclin d1 transcription was observed by the luciferase
reporter and RT-PCR assays (Fig. 4). As shown in Fig. 5A, the obvious
induction of both JNKs and Akt activation was observed in UVB-
treatedWT cells, which events were almost identically obtained in the
IKKα−/− cells under the same conditions. However, ERK activation
was weak and only discernable under high doses of UVB stimulation
in WT cells, but it was signiﬁcantly upregulated by IKKα deﬁciency.
Furthermore, re-introduction of IKKα into the null cells decreased
ERK activation while without affecting the inducible JNKs phosphor-Fig. 4. IKKα suppresses UVB-induced cyclin d1 transcription. (A) A Cyclin D1 promoter-driv
transfectants were established. The cells were then exposed to different doses of UVB and t
were exposed to different doses of UVB and RT-PCR assay was performed 12h after stimul
normalized to the β-actin control are presented. (C) WT, IKKα−/− and IKKα−/− (IKKα) ce
different doses of UVB and their luciferase activities were measured 12h after stimulation.ylation (Fig. 5B). These data indicate that IKKα speciﬁcally suppresses
ERK activation, which may be the upstream signaling event respon-
sible for downregulating cyclin d1 transcription in the UVB response.
To further address the relevance of ERK activation to UVB-induced
cyclin d1 transcription, we next analyzed the Cyclin D1 luciferase
reporter activity in both UVB-treated WT and IKKα-null cells after
pretreatment with the ERK inhibitor PD98059. The efﬁciency of
PD98059 on the suppression of UVB-induced ERK activation was
conﬁrmed bywestern-blot assay (data not shown). The results shown
in Fig. 5C and D indicate that pretreatment with PD98059 signiﬁcantly
decreased UVB-induced cyclin d1 transcription in both WT and IKKα-
null cells, as determined by the luciferase reporter (Fig. 5C) and the
RT-PCR (Fig. 5D) assays. These data thus indicate a novel role for
IKKα in negatively regulating UVB-induced cyclin d1 transcription by
suppressing inducible ERK activation.
4. Discussion
IKKα is amulti-functional signaling proteinwhose activities can be
exerted through, or independent of, its action on NF-κB activation
[8,18–26,36]. The implication of IKKα in the control of cellular growth
properties in both normal and tumor cells under physiological and
pathological conditions has been well-described in previous reports
[8,25–27,35–37]. The data in the current study have extended the
biological signiﬁcance of IKKα in cell growth control to the cellular
DNA damage response by disclosing a novel function of IKKα in
mediating the growth arrest response to UVB irradiation. Moreover,
this function of IKKα is unrelated to IKKβ/NF-κB activation status.
Along with our recent ﬁnding that IKKα is also involved in the growth
inhibition response induced by nickel compounds in human cells [34],
we thus anticipate that the anti-proliferative function of IKKα might
be important for cells to escape from the damage response induced by
certain environmental stressors.
In the following study to investigate the molecular mechanism of
IKKα in mediating the UVB-induced G0/G1 growth arrest response,
we found that the anti-proliferative effect of IKKα during the cellular
UVB response is largely related to downregulation of Cyclin D1en luciferase reporter plasmid was transfected into WT and IKKα-null cells and stable
he luciferase activity was measured 12h after stimulation. (B) WT and IKKα-null cells
ation to detect cyclin d1 transcripts. The relative expression levels of cyclin d1 mRNA
lls stably transfected with the Cyclin D1-luciferase reporter plasmid were exposed to
Fig. 5. IKKα suppresses cyclin d1 transcription during the UVB response by targeting the ERK-dependent pathway. (A) WT, IKKβ−/− and IKKα−/− cells were exposed to different
doses of UVB and the activation status of ERKs, JNKs and Akt was determined by western-blot assay 12h after UVB exposure. (B) WT, IKKα−/− and IKKα−/− (IKKα) cells were
exposed to different doses of UVB and the activation status of ERKs was determined by western-blot assay 12h after exposure. The detection of JNKs activation under the same
conditions was used as a negative control in this assay. (C) WT and IKKα−/− cells stably transfected with the Cyclin D1-luciferase reporter plasmid were pretreated with 50μM
PD98059 or its vehicle (DMSO) for 1h followed by exposure to different doses of UVB. The luciferase activity was detected 12h after UVB exposure. (D). WT and IKKα−/− cells were
exposed to PD98059 and UVB as in Fig. 5C and RT-PCR assay was performed to detect the cyclin d1 transcripts 12h after UVB exposure. The relative expression levels of cyclin d1
mRNA normalized to the expression of β-actin are presented.
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published data obtained in human cancer cells that demonstrates a
similar role for IKKα in the suppression of Cyclin D1 expression in the
nickel compound-induced growth inhibition response [34]. Taken
together, these studies thus implicate a general and evolutionarily
conserved role for IKKα in the negative regulation of Cyclin D1 levels
under stress conditions.
Indeed, as one of the most important downstream mediators of
IKKα, Cyclin D1 levels have been proved to be regulated by IKKα via
multiple mechanisms. According to a report from Dr. Verma's group,
IKKα directly binds to and phosphorylates Cyclin D1 on Thr286,
subsequently promoting the nuclear export and ubiquitin-dependent
degradation of Cyclin D1 in resting MEFs [35]. In the current study,
we consistently found that the half-life of endogenous Cyclin D1
was extended in untreated IKKα-null cells compared to parental cells
(Fig. 2C), further conﬁrming the notion that IKKα contributes to
maintaining the turnover and normal cellular levels of Cyclin D1
under physiological conditions. Moreover, IKKα was also shown to
possess the activity to rapidly increase the degradation of Cyclin D1
via the proteasome pathway after UVB exposure (Fig. 2B and C). In
combination of these data, we propose that IKKα is involved in the
regulation of Cyclin D1 protein stability under both physiological and
stress conditions. However, different from the direct action of IKKα onmodulating Cyclin D1 basal levels [35], our data indicate that the
activity of IKKα in promoting Cyclin D1 degradation under UVB
exposure is indirect and elicited by the induced activation of p38K, as
evidenced by reduced Cyclin D1 phosphorylation and rescued Cyclin
D1 degradation in SB202190-pretreated WT MEFs with normal
expression levels of IKKα (Fig. 3C and D). Therefore, we have for
the ﬁrst time deﬁned the functional link between IKKα and p38K in
modulating Cyclin D1 protein stability in response to UVB irradiation.
In addition, our results also add further evidence to theprevious notion
that p38K is largely responsible for mediating Cyclin D1 degradation
following exposure to environmental stressors or genotoxic insults
[14,15].
Aside from its role in regulating post-translational modiﬁcation of
CyclinD1, IKKα also has an effect on reducing cyclin d1 transcription in
the UVB response. However, in contrast to our results, numerous
previous studies have deﬁned a positive role for IKKα in the tran-
scriptional induction of cyclin d1 in response to Wnt, RANK and
estrogen signals [7,8,37,38]. Furthermore, investigations of the under-
lyingmechanism have demonstrated that IKKα can associate with the
NF-κB-responsive promoter and phosphorylates the transcriptional
co-activator or histone H3, therefore facilitating the transcription of
NF-κB-responsive genes, including cyclin d1 [18,19,38]. In another
case, IKKα has been shown to contribute to cyclin d1 transcription via
Fig. 6. Proposed scheme of the role of IKKα in mediating the UVB-induced G0/G1 cell
cycle arrest response by suppressing Cyclin D1 expression. Under UVB exposure, we
demonstrate a dual role of IKKα to selectively activate p38K and suppress ERK activation
in the early and late phases, respectively. The activation of p38K subsequently results in
increased phosphorylation and degradation of Cyclin D1; while the inhibition on ERK
activation suppresses the induced transcription of cyclin d1 under UVB irradiation. Due
to decreased protein stability and transcriptional suppression, the Cyclin D1 level is
downregulated in response toUVB and therefore cell cycle progression is arrested at G0/
G1 phase.
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conditions,wehave for theﬁrst time identiﬁed a negative role for IKKα
in the induction of cyclin d1 transcription, which effect is unrelated to
NF-κB activity andmediated by suppressing ERK activation. These data
suggest that IKKα has a dual role in the signaling events to trigger
cyclin d1 transcription via variousmechanisms under different cellular
growth conditions. It has been demonstrated that ERKs contribute to
cyclin d1 transcription by inducing the binding of the transcriptional
factor c-Ets2 to the Ets binding element in the cyclin d1 promoter
region [6]. Therefore, whether c-Ets2 is involved in IKKα-mediated
cyclin d1 transcriptional suppression will be addressed in future
investigations.
Notably, although our data, and that of previous studies [8,25,26,
35–37], emphasize the role of IKKα in Cyclin D1 regulation, it does not
mean that these effects are absolutely distinct for IKKα and not shared
by its structural and functional congener, IKKβ. In fact, although the
growth arrest response under UVB exposure was not affected by IKKβ
deﬁciency (Fig. 1C), we were unexpecting to ﬁnd that the protein
expression level of Cyclin D1 was extremely low in IKKβ-null cells
(Figs. 1D and2E). However,we excluded the possibility that lowCyclin
D1 expression levels in IKKβ-null cells were due to the deﬁcient
transcription, evidenced by the almost identical levels of cyclin d1
mRNA transcripts in WT and IKKβ-null cells (data not shown). In
addition, Cyclin D1 protein levels were efﬁciently recovered in IKKβ-
null cells by IKKβ reconstitution. Moreover, MG132 treatment caused
Cyclin D1 accumulation in the IKKβ-null cells at levels similar to WT
cells (data not shown). These data thus also disfavor the notion of
abnormal Cyclin D1 protein stability caused by IKKβ deletion.
Therefore, whether IKKβ deﬁciency affects the translational efﬁciency
of cyclin d1 mRNA is a subject worthy of investigation.
In summary, this study has demonstrated that IKKα is an impor-
tant factor for initiating the UVB-induced G0/G1 growth arrest
response by downregulating Cyclin D1 expression, which is a compre-
hensive effect, resulting from an increase of p38 kinase-dependent
Cyclin D1 proteolysis coupled with the reduction of ERK-dependent
Cyclin D1 transcription (Fig. 6). As UVB has been established as a risk
factor for the incidence of skin cancers, further evaluating the rele-
vance of IKKα deregulation in the process of UVB-induced tumori-
genesis is therefore of medical importance.
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